European Journal of Pediatrics

, Volume 152, Issue 11, pp 935–938 | Cite as

Elevated beta-endorphin immunoreactivity in the cerebrospinal fluid in victims of sudden infant death correlates with hypoxanthine in vitreous humour

  • H. Storm
  • T. O. Rognum
  • O. D. Saugstad
  • K. L. Reichelt


Beta-endorphin (BEND) may induce respiratory depression. Elevated levels of beta-endorphin immunoreactivity (BENDI) in the CSF are found in children with apnoea and in about 50% of sudden infant death (SID) victims. Premortal hypoxia in SID victims has been indicated by elevated hypoxanthine (HX) levels in the vitreous humour (VH). In this study we correlated BENDI in CSF with HX in VH in SID victims (n=19) and controls (n=18). BEND in CSF was measured by RIA, and HPLC was used for identification of BENDI. HX in VH was measured by HPLC. All the SID victims had elevated levels of HX in VH. The BENDI in CSF divided the SID victims into two subpopulations (P<0.01); one with undetectable levels (<4.3 fmol/ml) (n=10) and one with high levels (160–400 fmol/ml) (n=9).In the SID subpopulation with high levels of BENDI in CSF,we found a correlation between BENDI in CSF and HX in VH (r=0.92). Control infants who died a stressful death, such as during heart operations (n=2), had high levels of BENDI in CSF and low levels of HX in VH. Controls who died of infections (n=11) had low levels of BENDI in CSF and elevated levels of HX in VH. Because hypoxia in itself does not increase BENDI in CSF, increased BENDI in CSF is probably not secondary to hypoxia but may be of aetiological significance. We therefore suggest that SID victims with high levels of BENDI in CSF, which correlate with the elevated levels of HX in VH, may die from premortal hypoxia possibly induced by BEND.

Key words

Beta-endorphin Hypoxanthine Hypoxia SID 





beta-endorphin immunoreactivity


cerebrospinal fluid


high performance liquid chromatography






sudden infant death


vitreous humour


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Akil H, Watson SJ, Young E, Lewis ME, Khachatturain H, Walker JM (1984) Endogenous opioids. Biology and function. Ann Rev Neurosci 7:223–255PubMedGoogle Scholar
  2. 2.
    Brady JP, Chir B, Gould JB (1984) Sudden infant death syndrome the physisican's dilemma. Year book medical publisher, ChicagoGoogle Scholar
  3. 3.
    Burbach JPH, Loeber JG, Verhoff J, Kloet ER de, Van Ree JM, Wied D de (1979) Schizofrenia and degradation of endorphins in cerebrospinal fluid. Lancet II:480–481Google Scholar
  4. 4.
    Butterworth J, Tennant MC (1989) Postmortem human brain pH and lactate in sudden infant death syndrome. J Neurochem 53:1494–1499PubMedGoogle Scholar
  5. 5.
    Carey EM, Foster PC (1984) The activity of 2′,3′-cyclic nucleotide 3′-phosphohydrolase in corpus callosum, subcortical white matter,and spinal cord in infants dying from sudden infant death syndrome. J Neurochem 42(4):924–929PubMedGoogle Scholar
  6. 6.
    Farabollini F, Faccinetti F, Lupo C, Carli G (1990) Time course of opioid and pituriary-adrenal hormone modifications during the immobility reaction in rabbits. Physiol Behav 47: 337–341PubMedGoogle Scholar
  7. 7.
    Freedman A, Scardella AT, Edelman NH, Santiago TV (1988) Hypoxia does not increase CSF or plama beta-endorphin activity. J Appl Physiol 7:223–255Google Scholar
  8. 8.
    Gilbert-Barness E,Valdes-Dapena M, Steinschneider A, Chandra S (1992) Reproducibility of Naeye's seven tissue markers of hypoxia. Pediatric Pathology 12(3):481–482PubMedGoogle Scholar
  9. 9.
    Hassen AH, Feuerstein G, Faden AJ (1982) My receptors and opioid cardiovascular effects in the NTS of rat. Peptides 3: 1031–1037PubMedGoogle Scholar
  10. 10.
    Kelly DH, Pathak A, Meny R (1991) Sudden severe bradycardia in infancy. Pediatr Pulmonol 10:199–204PubMedGoogle Scholar
  11. 11.
    Kinney HC, Burger PC, Harell FE, Hudson RP (1983) Reactive gliosis in the medulla oblongata of victims of the sudden infant death syndrome. Pediatrics 72:181–187PubMedGoogle Scholar
  12. 12.
    Myer EC, Morris DL, Adams ML, Brase DA, Dewey WL (1987) Increased cerebrospinal fluid beta-endorphin immunoreactivity in infants with apnea and siblings of victims of sudden infant death syndrome. J Pediatr 111(5):660–666PubMedGoogle Scholar
  13. 13.
    Myer EC, Morris DL, Brase DA, Dewey WL, Zimmerman AW (1990) Naltrexone therapy of apnea in children with elevated cerebrospinal fluid beta-endorphin. Ann Neurol 27(1): 75–80PubMedGoogle Scholar
  14. 14.
    Naeye RL (1973) Pulmonary arterial abnormalities in the sudden infant death syndrome. N Engl J Med 289:1167–1170PubMedGoogle Scholar
  15. 15.
    Naeye RL (1980) Sudden infant death Sci Am:242–256Google Scholar
  16. 16.
    Naeye RL (1980) Brainstem and adrenal abnormalities in the sudden infant death syndrome. Am J Clin Pathol 66:526–530Google Scholar
  17. 17.
    Naeye RL, Fisher R, Rubin R, Demers LM (1980) Selected hormone levels in victims of the sudden infant death syndrome. Pediatrics 65:1134–1136PubMedGoogle Scholar
  18. 18.
    Nemeroff CB, Berger PA, Bissette G (1987) Peptides in schizophrenia. In: Meltzer HY (ed) Psychopharmalogy: the third generation of progress. Raven Press, New York pp 727–743Google Scholar
  19. 19.
    Parker JC (1981) The brainstem in sudden infant death syndrome. A postmortem survey. Am J Forensic Med Pathol 2(2): 121–127PubMedGoogle Scholar
  20. 20.
    Richards PT, Cuzner ML (1987) Proteolytic activity in CSF. Adv Exp Med Biol 100:521–527Google Scholar
  21. 21.
    Rognum TO, Saugstad OD (1993) Biochemical and immunologycal studies in SIDS victims. Clues to the understanding of the death mechanism. Acta Pediatr Scand [Suppl] 389:82–85Google Scholar
  22. 22.
    Rognum TO, Saugstad OD (1991) Hypoxanthine levels in vitreous humor: evidence of hypoxia in most infants who died of sudden infant death syndrome. Pediatrics 87:306–310PubMedGoogle Scholar
  23. 23.
    Rognum TO, Saugstad OD, Øyasæter S, Olaisen B (1988) Elevated levels of hypoxanthine in vitreous humor indicate prolonged cerebral hypoxia in victims of sudden infant death syndrome. Pediatrics 82:615–618PubMedGoogle Scholar
  24. 24.
    Shook JE, Watkins WD, Camporesi EM (1990)Differential roles of opioid receptors in respiration, repiratory disease, and opiate-induced respiratory depression. Am Rev Respir Dis 142: 895–909PubMedGoogle Scholar
  25. 25.
    Southall DP, Samuels MP, Talbert DG(1990) Recurrent cyanotic episodes with severe arterial hypoxaemia and intrapulmonary shunting: a mechanism for sudden death. Arch Dis Child 65:953–961PubMedGoogle Scholar
  26. 26.
    Storm H, Reichelt KL, Rognum TO (1990) Beta-endorphin, human caseomorphin and bovine caseomorphin immunoreactivity in CSF in sudden infant death syndrome and controls. Preceeding of the International Narcotics Research Conference (INRC) 1989. Alan R Liss Inc, New York, pp 327–330Google Scholar
  27. 27.
    Takashima S, Armstrong D, Becker LE (1978) Cerebral white matter lesions in sudden infant death syndrome. Pediatrics 62: 155–159PubMedGoogle Scholar
  28. 28.
    Takashima S, Armstrong D, Becker L, Bryan C (1978) Cerebral hypoperfusion in the sudden infant death syndrom? Brainstem gliosis and vasculature. Ann Neurol 4(3):257–262PubMedGoogle Scholar
  29. 29.
    Valdes-Dapena (1992) The sudden infant death syndrome: pathologic findings. Clin Perinatol 19(4):701–716PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1993

Authors and Affiliations

  • H. Storm
    • 1
  • T. O. Rognum
    • 2
  • O. D. Saugstad
    • 1
  • K. L. Reichelt
    • 1
  1. 1.Department of Paediatric ResearchThe National HospitalOslo 1Norway
  2. 2.Institute of Forensic MedicineThe National HospitalOslo 1Norway

Personalised recommendations